Karlsson, J. O. G., Jynge, P., Lundström, I., & Ignarro, L. J. (2019). Letter in response to: “Randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with the 12-h regimen of N acetylcysteine for paracetamol overdose—the PP100-01 for Overdose of Paracetamol (POP) trial: study protocol for a randomised controlled trial”. Trials.
Citação norma ChicagoKarlsson, Jan Olof G., Per Jynge, Ingemar Lundström, and Louis J. Ignarro. "Letter in Response To: “Randomised Open Label Exploratory, Safety and Tolerability Study With Calmangafodipir in Patients Treated With the 12-h Regimen of N Acetylcysteine for Paracetamol Overdose—the PP100-01 for Overdose of Paracetamol (POP) Trial: Study Protocol for a Randomised Controlled Trial”." Trials 2019.
Citação norma MLAKarlsson, Jan Olof G., Per Jynge, Ingemar Lundström, and Louis J. Ignarro. "Letter in Response To: “Randomised Open Label Exploratory, Safety and Tolerability Study With Calmangafodipir in Patients Treated With the 12-h Regimen of N Acetylcysteine for Paracetamol Overdose—the PP100-01 for Overdose of Paracetamol (POP) Trial: Study Protocol for a Randomised Controlled Trial”." Trials 2019.